Corporate information
Registration country
Company type
Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseasesFunding rounds
Series B
( )
Investor | Profile | Country | Notes | |
---|---|---|---|---|
MPM Capital | Initial investment. | |||
Prospect Venture Partners | Venture capital firm | Initial investment. | ||
Schroder Ventures Life Sciences Inc | Initial investment. | |||
Essex Woodlands Health Ventures Inc | Follow-on investment. | |||
Technology Partners. | Venture capital firm | Follow-on investment. |
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Essex Woodlands Health Ventures Inc | Initial investment. | |||
Technology Partners. | Venture capital firm | Initial investment. |
Investment activity status
Active investor